EUVIMEDEUVIMED entdecken
Kohortenstudie

Long‐term all‐cause mortality of metabolic‐dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study

Jaycie Koh, Ayman Mohamed, Gwyneth Kong, Esther Wong, Yiming Chen, Vickram Vijay Anand, Bryan Chong, Yip Han Chin, Jiong-Wei Wang iD, Chin Meng Khoo, Siew Pang Chan, Mark Muthiah iD und 4 weitere

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.16062 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Jaycie Koh und 15 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. Hauptthemen laut MEDLINE: Myocardial Infarction, Phenotype, Obesity, Body Weight. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: National Medical Research Council Research Training Fellowship, NUHS Clinician Scientist Program, National University of Singapore Yong Loo Lin School of Medicine's Junior Academic Fellowship Scheme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Metabolic dysfunction‐associated steatotic liver disease (MASLD) and obesity increases risk of cardiovascular disease. This cohort study examines the prognostic value of MASLD, across body weight categories, in a secondary preventative acute myocardial infarction (AMI) cohort.

Methods

Patients with AMI were stratified into four phenotypes—obesity MASLD, non‐obesity MASLD, obesity non‐MASLD, non‐obesity non‐MASLD. The primary outcome was all‐cause mortality. Cox regression analysis was performed to investigate determinants of long‐term all‐cause mortality.

Results

Of 5702 patients, majority were in the non‐obesity non‐MASLD group (66.7%), followed by obesity MASLD (16.1%), non‐obesity MASLD (11.2%) and non‐obesity MASLD (6.0%). Across the four phenotypes, obesity MASLD had the highest cardiometabolic burden, followed by non‐obesity MASLD. Non‐obesity MASLD had the highest risk of heart failure ( p = 0.034), cardiogenic shock ( p < 0.001), and all‐cause long‐term mortality ( p = 0.019). The non‐obesity MASLD (HR 1.400, 95%CI 1.077–1.820, p = 0.012) and obesity MASLD phenotypes (HR 1.222, 95%CI 1.005–1.485, p = 0.044) were independently associated with long‐term all‐cause mortality.

Conclusions

Obesity and non‐obesity MASLD phenotypes were predictors of all‐cause mortality following AMI, with an even larger magnitude of mortality risk in the non‐obesity MASLD group. The recognition of MASLD and its body weight phenotypes will be beneficial in the prognostication following AMI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionPhenotypeObesityBody WeightHumansMaleFemaleMiddle AgedRetrospective StudiesAgedPrognosisFatty LiverRisk FactorsNon-alcoholic Fatty Liver DiseaseCohort Studies

Stichwörter der Autor:innen

MASLDacute myocardial infarctionmortalityobesityprognosis

Autor:innen und Institutionen

  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • King Fahd Military Medical Complex, Dhahran, Saudi Arabia.
  • Department of Cardiology, National University Heart Centre, National University Health System, Singapore, Singapore.
  • Cardiology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Department of Medicine, National University Hospital, Singapore, Singapore.
  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

ORCID-Profile: Jiong-Wei Wang, Mark Muthiah, Nicholas W S Chew

Förderung

  • National Medical Research Council Research Training Fellowship
  • NUHS Clinician Scientist Program
  • National University of Singapore Yong Loo Lin School of Medicine's Junior Academic Fellowship Scheme
  • NUHS Seed Fund

Zitieren

APA

Koh, J., Mohamed, A., Kong, G., Wong, E., Chen, Y., Anand, V. V., Chong, B., Chin, Y. H., Wang, J. W., Khoo, C. M., Chan, S. P., Muthiah, M., Dimitriadis, G. K., Chan, M. Y., Loh, P. H., & Chew, N. W. S. (2025). Long‐term all‐cause mortality of metabolic‐dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16062

Vancouver

Koh J, Mohamed A, Kong G, Wong E, Chen Y, Anand VV, et al. Long‐term all‐cause mortality of metabolic‐dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16062

BibTeX
@article{Koh2025,
  author = {Koh, Jaycie and Mohamed, Ayman and Kong, Gwyneth and Wong, Esther and Chen, Yiming and Anand, Vickram Vijay and Chong, Bryan and Chin, Yip Han and Wang, Jiong-Wei and Khoo, Chin Meng and Chan, Siew Pang and Muthiah, Mark and Dimitriadis, Georgios K and Chan, Mark Yan-Yee and Loh, Poay-Huan and Chew, Nicholas W S},
  title = {Long‐term all‐cause mortality of metabolic‐dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.16062}
}
Kostenlos starten →